NUAK1 has been reported to inactivate glycogen synthase kinase-3 beta (GSK3β) by suppressing the de-phosphorylation pathway of GSK3β Ser9 in colorectal cancer cells (Yang et al. 2021). This evidence concerns the gene GSK3B and colorectal cancer.